Advances in biomarkers for immunotherapy in small-cell lung cancer

Small-cell lung cancer (SCLC) is a refractory cancer with rapid growth and high aggressiveness. Extensive-stage SCLC is initially sensitive to chemotherapy; however, drug resistance and recurrence occur rapidly, resulting in a poor survival outcome due to lack of subsequently efficient therapy. The...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hui Li, Peiyan Zhao, Lin Tian, Yuanhua Lu, Xinyue Wang, Wenjun Shao, Ying Cheng
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Assuntos:	small-cell lung cancer immunotherapy biomarker research advances predictive prognosis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1490590/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!